Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Fetal fibronectin testing for reducing the risk of preterm birth

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD006843Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Embarazo y parto

Copyright:
  1. Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Vincenzo Berghella

    Correspondencia a: Director, Division of Maternal Fetal Medicine, Thomas Jefferson University, Philadelphia, USA

    [email protected]

  • Edward Hayes

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

  • John Visintine

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

  • Jason Baxter

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

Contributions of authors

Jason Baxter, Edward Hayes, and John Visintine:
1. helped with the initial idea of a fetal fibronectin review;
2. met several times with main author (Vincenzo Berghella) regarding all aspects of the development of the protocol;
3. contributed and edited to the writing of the protocol;
4. helped to revise and respond to the feedback received on the first draft of the protocol.

Vincenzo Berghella (VB) prepared the first draft and finalised the revised draft of the protocol in response to feedback. VB is the guarantor of the review.

Declarations of interest

None known.

Acknowledgements

As part of the pre‐publication editorial process, this protocol has been commented on by two peers (an editor, and a referee who is external to the editorial team), one or more members of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.

Version history

Published

Title

Stage

Authors

Version

2019 Jul 29

Fetal fibronectin testing for reducing the risk of preterm birth

Review

Vincenzo Berghella, Gabriele Saccone

https://doi.org/10.1002/14651858.CD006843.pub3

2008 Oct 08

Fetal fibronectin testing for reducing the risk of preterm birth

Review

Vincenzo Berghella, Edward Hayes, John Visintine, Jason K Baxter

https://doi.org/10.1002/14651858.CD006843.pub2

2007 Oct 17

Fetal fibronectin testing for reducing the risk of preterm birth

Protocol

Vincenzo Berghella, Edward Hayes, John Visintine, Jason Baxter

https://doi.org/10.1002/14651858.CD006843

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.